Anti-Snoring Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

Anti-Snoring Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

Anti Snoring Devices Market by Device Type (Mandibular Advancement Devices, Tongue Stabilizing Devices, Continuous Positive Airway Pressure (CPAP) Devices, and Others), Distribution Channel (Hospital and Retail Pharmacies, Online Pharmacies, and Others), Usability (Reusable and Disposable), Application (Vaccine, Insulin, Dermatology, and Others), End-User (Hospitals, Clinics, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of sleep apnea and its risk factors such as depression, COPD, obesity, surging number of sleep awareness campaigns and programs, among others across the globe.

The anti snoring devices market was valued at USD 1.61 billion in 2023, growing at a CAGR of 7.02% during the forecast period from 2024 to 2030 to reach USD 2.58 billion by 2030. The anti snoring devices market is poised for substantial growth, owing to the increasing prevalence of sleep disorders and risk factors such as depression, COPD, and obesity, among others, surge in the number of sleep awareness campaigns and programs highlighting the importance of sleep, the rising launch of technologically advanced sleep devices during the forecast period from 2024 to 2030.

Anti Snoring Devices Market Dynamics:

As per DelveInsight analysis, in 2021, the estimated total diagnosed cases of obstructive sleep apnea (OSA) in the 7MM region was 24,165,544. According to World Health Organization 2021, worldwide around 280 million people were suffering from depression in 2019. Several research studies have concluded that individuals going through depression may find it difficult to fall and stay asleep during the night or experience periods of excessive daytime sleepiness.

As per data from the Global Burden of Disease Study, there were 212.3 million prevalent cases of COPD reported in 2019 globally. COPD causes persistent and progressive respiratory symptoms, including difficulty in breathing, cough, and phlegm production. Thus, people with COPD will also have sleep apnea, the combination leading to a condition called ""overlap syndrome“.

Severe conditions such as obesity also aggravate the symptoms of various sleep disorders that may disrupt the sleep quality of an individual. In obese people, fat deposits in the upper respiratory tract narrow the airway; decreasing muscle activity in this region, leading to hypoxic and apneic episodes, ultimately resulting in sleep discrepancies such as sleep apnea. Thus, the interplay of all the above-mentioned factors is expected to boost the market for anti snoring devices during the forecasted period.

However, the various complications associated with anti snoring devices, the unreliable efficacy, and the lack of proven studies for the use of anti snoring devices, among others may act as restraining factors for the overall growth of the anti snoring devices during the forecast period.

Anti Snoring Devices Market Segment Analysis:

Anti Snoring Devices Market by Device Type (Mandibular Advancement Devices, Tongue Stabilizing Devices, Continuous Positive Airway Pressure (CPAP) Devices, and Others), Distribution Channel (Hospital and Retail Pharmacies, Online Pharmacies, and Others), Usability (Reusable and Disposable), Application (Vaccine, Insulin, Dermatology, and Others), End-User (Hospitals, Clinics, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the device type segment of the anti-snoring devices market, the Continuous Positive Airway Pressure (CPAP) Devices category is projected to hold a considerable market share in 2023. The various advantages associated with CPAP therapy and the various product development activities such as launches are expected to drive the market demand for this category during the forecast period.

CPAP ventilators deliver a constant pressure of air, both while inhaling and exhaling, due to which CPAP ventilators form one of the most common forms of treatment procedures for the management of mild obstructive sleep apnea. CPAP includes automatic PAP therapy (APAP) as well, which uses an automatically adjusting positive airway pressure machine to treat obstructive sleep apnea. APAP devices may also be referred to as auto-titrating CPAP or auto-CPAP machines.

Moreover, in February 2024, ResMed announced the launch of its AirFit F40 ultra-compact, full-face mask indicated for sleep apnea. The device offers the comfort of smaller masks without sacrificing performance, thus helping with sleep apnea therapy compliance for users of high-pressure continuous positive airway pressure (CPAP) treatment.

Thus, all the above-mentioned factors are expected to boost the market for the CPAP category, thereby escalating the overall market for anti snoring devices during the forecast period.

North America is expected to dominate the overall anti snoring devices market:

North America is expected to account for the highest proportion of the Anti Snoring Devices market in 2023, out of all regions North America is expected to dominate the overall Anti Snoring Devices market during the forecast period.

The major factors driving the market for anti snoring devices in North America are the rising prevalence of sleep-related issues among the population, the presence of key organizations for creating awareness, and product development activities, among other activities across the region during the forecast period. As per data by the Centers for Disease Control and Prevention 2022, around 17.8% of adults had trouble staying asleep owing to various reasons such as sleep apnea in the US in 2020.

Further, the American Sleep Apnea Association 2023 stated that nearly 84 million people which means one in three American adults do not get the required uninterrupted sleep due to snoring and breathing difficulties regularly.

The presence of organizations such as the National Sleep Foundation (NSF), independently creates Sleep Awareness Week each year as the flagship campaign for sleep health awareness and education in the US.

NSF recognizes evidence and consensus-based best practices for sleep health throughout Sleep Awareness Week, including professional advice and useful pointers to assist people in getting the necessary quantity and quality of sleep.

Thus, the interplay of all the aforementioned factors is likely to fuel the regional market growth and demand for anti snoring devices in North America during the forecasted period from 2024 to 2030.

Anti Snoring Devices Market Key Players:

Some of the key market players operating in the Anti Snoring Devices market include Koninklijke Philips NV, Apnea Sciences, ResMed, SomnoMed, GSK plc., Meditas, Evantis Inc., Rotech Healthcare, The Pure Sleep Company, Innovative Health Technologies, Tomed GmbH, Fisher and Paykel Healthcare Limited, Whole You Inc., AccuMED Corporation, Vyaire Medical, and others.

Recent Developmental Activities in the Anti Snoring Devices Market:

In July 2024, Snorles, a leading innovator in sleep technology, announced the launch of its latest product, GenioFlex, which offers a fresh approach to managing snoring without the need for intrusive nighttime devices. Snorles GenioFlex distinguishes itself by its unique daytime functionality, eliminating the need for users to wear or use it during sleep hours. Unlike traditional anti-snoring products that may disrupt sleep quality, GenioFlex seamlessly integrates into daily routines, providing effective snoring management without compromising nighttime rest.

In May 2022, Illusion Aligners, known for bringing revolutionary technologies to the dental industry, launched its new Anti-Snoring Device (ASD). The oral anti-snoring device by Illusion Aligners is easy to wear, effective, and is also comfortable. It can help experience undisturbed and restful sleep every night.

In February 2021, the U.S. Food and Drug Administration authorized the marketing of a new prescription-only device, the eXciteOSA mouthpiece, intended to reduce snoring and mild obstructive sleep apnea. Unlike devices used while patients sleep, this was the first device used while awake, intended to improve tongue muscle function, which in time can help prevent the tongue from collapsing backward and obstructing the airway during sleep.

Key Takeaways from the Anti Snoring Devices Market Report Study:

Market size analysis for current Anti Snoring Devices size (2023), and market forecast for 6 years (2024 to 2030)

Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.

Key companies dominating the Anti Snoring Devices market.

Various opportunities available for the other competitors in the Anti Snoring Devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current Anti Snoring Devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for anti snoring devices market growth in the coming future?

Target audience who can be benefited from this Anti Snoring Devices Market Report Study:

Anti Snoring Devices product providers

Research organizations and consulting companies

Anti Snoring Devices - related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and traders dealing in Anti Snoring Devices

Various end-users who want to know more about the Anti Snoring Devices market and the latest technological developments in the Anti Snoring Devices market.

Frequently Asked Questions for the Anti Snoring Devices Market:

1. What are Anti Snoring Devices?

Anti snoring devices are devices that help keep the nasal passages open and relieve snoring. Nasal snoring can be relieved with the use of nasal anti-snoring devices such as nasal strips, and nasal dilators, among others that keep the nostrils open during sleep.

2. What is the market for Anti Snoring Devices?

The anti snoring devices market was valued at USD 1.61 billion in 2023, growing at a CAGR of 7.02% during the forecast period from 2024 to 2030 to reach USD 2.58 billion by 2030.

3. What are the drivers for the Anti Snoring Devices market?

The anti snoring devices market is poised for substantial growth, owing to the increasing prevalence of sleep disorders and risk factors such as depression, COPD, and obesity, among others, the surge in the number of sleep awareness campaigns and programs highlighting the importance of sleep, the rising launch of technologically advanced sleep devices during the forecast period from 2024 to 2030.

4. Who are the key players operating in the Anti Snoring Devices market?

Some of the key market players operating in the Anti Snoring Devices market include Koninklijke Philips NV, Apnea Sciences, ResMed, SomnoMed, GSK plc., Meditas, Evantis Inc., Rotech Healthcare, The Pure Sleep Company, Innovative Health Technologies, Tomed GmbH, Fisher and Paykel Healthcare Limited, Whole You Inc., AccuMED Corporation, Vyaire Medical, and others.

5. Which region has the highest share in the Anti Snoring Devices market?

North America is expected to account for the highest proportion in the Anti Snoring Devices market in 2023, out of all regions. The major factors driving the market for anti snoring devices in North America are the rising prevalence of sleep-related issues among the population, the presence of key organizations for creating awareness, and product development activities, among other activities across the region during the forecast period.